Literature DB >> 15466921

Effects of endogenous estrogen on renal calcium and phosphate handling in elderly women.

I M Dick1, A Devine, J Beilby, R L Prince.   

Abstract

High postmenopausal endogenous estrogen concentrations are an important determinant of preservation of bone mass and reduced fracture in elderly women. Calcium supplementation can also reduce bone loss in these patients, suggesting an interaction between estrogen deficiency and calcium balance. Potential mechanisms of estrogen on calcium transport include direct effects on the bone, the kidney, and the bowel. Previous studies have demonstrated effects of estrogen on renal phosphate handling. We have used a cross-sectional, population-based analysis of biochemical data obtained from ambulant elderly women to determine the association of endogenous estradiol with urine calcium and phosphorus excretion. The subjects were 293 postmenopausal women >70 yr old. Factors associated with renal calcium and phosphate excretion were measured, including the filtered calcium and phosphate load, parathyroid hormone (PTH), estradiol, and sex hormone-binding globulin (SHBG). The free estradiol concentration (FE) was calculated from a previously described formula. A high plasma estradiol concentration (r(2) = 0.023, P = 0.01) and a high FE (r(2) = 0.045, P = 0.001) were associated with reduced renal calcium excretion. The estradiol and FE effect on renal calcium excretion remained significant after adjusting for calcium filtered at the glomerulus and serum PTH. A high FE was associated with a reduced renal phosphate threshold in univariate analysis (r(2) = 0.023, P = 0.010). The effect remained significant after adjustment for serum PTH. The size of the effect of the FE was of the same order of magnitude as the effect of PTH on reducing renal calcium excretion and increasing renal phosphate excretion. These data support in vitro and animal data demonstrating an effect of estradiol on renal calcium and phosphate handling and indicate that, in elderly postmenopausal women, the effect is of a similar magnitude to the well-recognized effects of PTH on these physiologically regulated parameters.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466921     DOI: 10.1152/ajpendo.00140.2004

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  21 in total

1.  Increased PTHrP and decreased estrogens alter bone turnover but do not reproduce the full effects of lactation on the skeleton.

Authors:  Laleh Ardeshirpour; Susan Brian; Pamela Dann; Joshua VanHouten; John Wysolmerski
Journal:  Endocrinology       Date:  2010-11-03       Impact factor: 4.736

2.  Novel effects of phytoestrogenic soy isoflavones on serum calcium and chloride in premenopausal women: A 2-year double-blind, randomized, placebo-controlled study.

Authors:  Lee-Jane W Lu; Nai-Wei Chen; Fatima Nayeem; V-M Sadagopa Ramanujam; Yong-Fang Kuo; Donald G Brunder; Manubai Nagamani; Karl E Anderson
Journal:  Clin Nutr       Date:  2017-11-11       Impact factor: 7.324

Review 3.  The physiology of endocrine systems with ageing.

Authors:  Annewieke W van den Beld; Jean-Marc Kaufman; M Carola Zillikens; Steven W J Lamberts; Josephine M Egan; Aart J van der Lely
Journal:  Lancet Diabetes Endocrinol       Date:  2018-07-17       Impact factor: 32.069

4.  Soy isoflavones interact with calcium and contribute to blood pressure homeostasis in women: a randomized, double-blind, placebo controlled trial.

Authors:  Lee-Jane W Lu; Nai-Wei Chen; Fatima Nayeem; Manubai Nagamani; Karl E Anderson
Journal:  Eur J Nutr       Date:  2019-09-18       Impact factor: 5.614

5.  The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea.

Authors:  Joo-Pin Foo; Stergios A Polyzos; Athanasios D Anastasilakis; Sharon Chou; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2014-08-22       Impact factor: 5.958

6.  Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study.

Authors:  Nisha Bansal; Ronit Katz; Ian H de Boer; Bryan Kestenbaum; David S Siscovick; Andrew N Hoofnagle; Russell Tracy; Gail A Laughlin; Michael H Criqui; Mathew J Budoff; Dong Li; Joachim H Ix
Journal:  J Clin Endocrinol Metab       Date:  2013-10-03       Impact factor: 5.958

7.  Osteoblast-activating peptide exhibits a specific distribution pattern in mouse ovary and may regulate ovarian steroids and local calcium levels.

Authors:  Ahmed E Noreldin; Mahmoud S Gewaily; Islam M Saadeldin; Mosleh M Abomughaid; Asmaa F Khafaga; Yaser H Elewa
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

8.  Olive oil effectively mitigates ovariectomy-induced osteoporosis in rats.

Authors:  Nermine K Saleh; Hanan A Saleh
Journal:  BMC Complement Altern Med       Date:  2011-02-04       Impact factor: 3.659

9.  Indirect regulation of PTH by estrogens may require FGF23.

Authors:  Natalia Carrillo-López; Pablo Román-García; Ana Rodríguez-Rebollar; José Luis Fernández-Martín; Manuel Naves-Díaz; Jorge B Cannata-Andía
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

10.  Sodium phosphate supplementation and time trial performance in female cyclists.

Authors:  Christopher L Buck; Brian Dawson; Kym J Guelfi; Lars McNaughton; Karen E Wallman
Journal:  J Sports Sci Med       Date:  2014-09-01       Impact factor: 2.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.